By: dr. Simone Albisinni , dr. Nick Liefhooghe , dr. Daan De Maeseneer , prof. dr. Pieter De Visschere , Prof Steven Van Laere
In line with the tradition, the BMUC scientific committee asked a urologist, a radiation oncologist and a medical oncologist to summarise the top stories that were presented during the large urology and oncology meetings of the previous year. In addition, this year’s Congress Highlights also included presentations discussing congress highlights in imaging and genomics.
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
